Combined aortic regurgitation (AR) and mitral regurgitation (MR) is a relatively common multiple valvular heart disease. Current guidelines recommend intervention (AVI and/or MVI) when either lesion becomes severe in the setting of symptoms, left ventricular (LV) systolic dysfunction or dilation, as in isolated s...
C. Ng, P. Santi, N. Elmasry et al.· European Heart Journal· 0 citations
Among asymptomatic patients with moderate-severe or severe chronic AR and preserved LVEF, elevated LAP is independently associated with increased long-term mortality, suggesting that markers of elevated LV filling pressures may improve risk stratification of these patients.
P. Santi, N. Elmasry, J. Bernard et al.· European Heart Journal· 0 citations
Comparable long-term survival was observed between SAA and No-SAA patients supporting the safety and effectiveness of TAVI in patients with SAA, and significant LV reverse remodeling and systolic functional improvement occur after TAVI regardless of aortic valve annular size.
H. Tang, P. Santi, Y. Obayashi et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.